High circulating anti-p53 titers almost invariably originate from conformationally altered (mutant) p53 that accumulates in tumor cells; these mutants not only mark heavy tumor burden but actively dampen innate‐immune sensors such as cGAS-STING and NF-κB signaling pathways [30,31]. This evidence concerns the gene TP53 and neoplasm.